VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PRI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PRIPrimerica, Inc.
$297.06$9.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPRIQuarterly Financials

Primerica, Inc. (PRI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Primerica, Inc. (PRI) quarterly income statement — complete revenue, gross profit & net income history

PRI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue856.81M838.34M839.77M793.27M804.84M788.11M774.13M790.96M735.95M726.34M697.5M688.38M690.04M686.94M673.29M668.68M691.23M724.09M693.24M654.69M
Revenue Growth %6.46%6.37%8.48%0.29%9.36%8.5%10.99%14.9%6.65%5.74%3.6%2.95%-0.17%-5.13%-2.88%2.14%8.39%21.02%21.95%24.51%
Medical Costs & Claims163.88M161.31M474.85M463.05M479.19M477.48M429.85M431.58M442.35M438.14M413.58M409.61M426.87M432.18M411.57M419.3M452.04M486.77M458.74M411.35M
Medical Cost Ratio %19.13%19.24%56.55%58.37%59.54%60.59%55.53%54.56%60.11%60.32%59.29%59.5%61.86%62.91%61.13%62.71%65.4%67.23%66.17%62.83%
Gross Profit692.93M677.02M364.92M330.23M325.66M310.63M344.28M359.37M293.6M288.2M283.92M278.77M263.17M254.76M261.72M249.38M239.18M237.32M234.5M243.33M
Gross Margin %80.87%80.76%43.45%41.63%40.46%39.41%44.47%45.44%39.89%39.68%40.71%40.5%38.14%37.09%38.87%37.29%34.6%32.77%33.83%37.17%
Gross Profit Growth %112.78%117.95%5.99%-8.11%10.92%7.78%21.26%28.91%11.57%13.13%8.48%11.79%10.03%7.35%11.61%2.49%14.76%17.11%10.07%23.26%
Operating Expenses443.51M429.95M93.24M95.73M104.34M92.12M89.7M86.6M100.22M91.16M77.53M89.88M96.23M87.21M140.59M86.54M93.29M171.02M87.39M73.87M
OpEx / Revenue %51.76%51.29%11.1%12.07%12.96%11.69%11.59%10.95%13.62%12.55%11.12%13.06%13.95%12.7%20.88%12.94%13.5%23.62%12.61%11.28%
Depreciation & Amortization04.92M4.31M5.25M4.77M4.32M4.59M7.32M7.17M7.17M7.36M8.89M8.55M8.54M8.28M8.66M8.69M10.14M8.93M5.36M
Combined Ratio %70.89%70.53%67.65%70.44%72.5%72.27%67.11%65.51%73.72%72.87%70.41%72.56%75.81%75.61%82.01%75.65%78.89%90.84%78.78%74.11%
Operating Income249.42M247.07M271.68M234.5M221.31M218.51M254.58M272.77M193.39M197.04M206.38M188.9M166.94M167.55M121.13M162.84M145.9M66.3M147.1M169.47M
Operating Margin %29.11%29.47%32.35%29.56%27.5%27.73%32.89%34.49%26.28%27.13%29.59%27.44%24.19%24.39%17.99%24.35%21.11%9.16%21.22%25.89%
Operating Income Growth %12.7%13.07%6.72%-14.03%14.44%10.9%23.35%44.4%15.84%17.6%70.38%16%14.43%152.72%-17.66%-3.91%13.71%-49.64%0.42%26.41%
EBITDA255.28M251.99M275.99M239.75M226.09M222.84M259.17M280.09M200.55M204.21M213.74M197.79M175.49M176.09M129.41M171.5M154.58M76.44M156.03M174.82M
EBITDA Margin %29.79%30.06%32.87%30.22%28.09%28.27%33.48%35.41%27.25%28.11%30.64%28.73%25.43%25.63%19.22%25.65%22.36%10.56%22.51%26.7%
Interest Expense5.86M5.97M20.46M20.62M6M6.07M6.09M6.1M6.77M6.59M6.63M6.69M6.69M6.77M6.8M6.81M6.85M8.8M7.53M7.14M
Non-Operating Income-5.86M-5.97M-5.99M-6M-6M-6.07M-6.09M-6.1M-6.77M-6.59M-6.63M-6.69M-6.69M-6.77M-6.8M-6.81M-6.85M-8.8M-7.53M-7.14M
Pretax Income249.42M247.07M271.68M234.5M221.31M218.51M254.58M272.77M193.39M197.04M206.38M188.9M166.94M167.55M121.13M162.84M145.9M66.3M147.1M169.47M
Pretax Margin %29.11%29.47%32.35%29.56%27.5%27.73%32.89%34.49%26.28%27.13%29.59%27.44%24.19%24.39%17.99%24.35%21.11%9.16%21.22%25.89%
Income Tax59.32M50.03M64.89M56.15M52.26M50.84M59.84M63.47M44.98M45.11M48.93M44.39M38.84M35.71M41.57M37.27M33.51M31.79M35.66M41.3M
Effective Tax Rate %23.78%20.25%23.88%23.95%23.62%23.26%23.51%23.27%23.26%22.89%23.71%23.5%23.27%21.31%34.32%22.88%22.97%47.95%24.24%24.37%
Net Income190.1M197.05M206.79M178.34M169.05M167.07M164.37M1.17M137.9M151.94M152.06M144.5M128.1M131.84M79.56M127.96M115.04M34.87M112.46M128.16M
Net Margin %22.19%23.5%24.62%22.48%21%21.2%21.23%0.15%18.74%20.92%21.8%20.99%18.56%19.19%11.82%19.14%16.64%4.82%16.22%19.58%
Net Income Growth %12.45%17.94%25.81%15130.06%22.59%9.96%8.1%-99.19%7.65%15.24%91.13%12.93%11.35%278.11%-29.25%-0.16%17.54%-65.16%0.32%26.26%
EPS (Diluted)5.976.136.355.405.054.964.830.033.934.304.233.973.383.561.383.312.070.872.823.22
EPS Growth %18.22%23.59%31.47%17152.4%28.5%15.35%14.18%-99.21%16.27%20.79%206.52%19.94%63.29%309.2%-51.06%2.79%-15.85%-65.48%0.36%28.29%
EPS (Basic)5.986.146.365.415.064.974.840.033.944.304.233.973.393.571.383.322.080.882.833.23
Diluted Shares Outstanding31.73M32.03M32.45M32.91M33.34M34.2M33.89M34.38M34.94M35.21M35.82M36.29M36.8M37.08M37.54M38.5M39.33M39.69M39.68M39.65M